Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis

The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer. PubMed, Embase, the Cochrane Library, the China National Knowl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 2018-03, Vol.97 (12), p.e0127-e0127
Hauptverfasser: Zhang, Dan, Wu, Jiarui, Wang, Kaihuan, Duan, Xiaojiao, Liu, Shi, Zhang, Bing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0127
container_issue 12
container_start_page e0127
container_title Medicine (Baltimore)
container_volume 97
creator Zhang, Dan
Wu, Jiarui
Wang, Kaihuan
Duan, Xiaojiao
Liu, Shi
Zhang, Bing
description The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer. PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure Database (CNKI), Wan-fang Database, Cqvip Database (VIP), China Biology Medicine disc (CBMdisc) were searched to identify RCTs which focused on CHIs against gastric cancer. The quality assessment of included randomized controlled trials (RCTs) was conducted by the Cochrane risk of bias tool. Standard pair-wise and Bayesian NMAs were performed to compare the efficacy and safety of different CHIs combined with the XELOX regimen via Stata 13.0 and WinBUGS1.4 software. A total of 2316 records were searched, the network of evidence included 26 eligible RCTs involving 13 types of CHIs and 2154 patients. The results suggested that Shenqifuzheng+ XELOX, Huachansu+ XELOX, Kangai+ XELOX, Javanica oil emulsion+ XELOX, Aidi injection+ XELOX might be the optimal treatment for gastric cancer in improving the performance status than using XELOX regimen single, with odds ratios (OR) and 95% confidence intervals (CIs) of 2.74 (1.24, 6.17), 8.27 (1.74, 42.43), 4.28 (1.80, 10.48), 5.14 (1.87, 16.28), 0.20 (0.090, 0.44). At the aspects of ADRs (adverse reactions), Compound Kushen+ XELOX, Lentinan+ XELOX, Xiaoaiping injection+ XELOX could obviously relieve leukopenia than only receiving XELOX regimen, and their ORs and 95% CIs were 5.62 (1.41, 36.24), 8.16 (2.25, 29.43), 5.69 (1.85, 15.77). Furthermore, Disodium cantharidinate and vitamin B6+ XELOX, Shenqifuzheng+ XELOX, Kangai+ XELOX, Lentinan+ XELOX could obviously relieve the nausea and vomiting than receiving the XELOX regimen alone, with ORs and 95% CIs of 5.29 (1.30, 23.96), 2.50 (1.16, 5.26), 2.42 (1.06, 5.63), 9.04 (3.24, 26.73). Nevertheless, CHIs combined with XELOX regimen did not confer higher better clinical effectiveness rate over receiving XELOX regimen alone, with nonstatistically significant between-group differences. As the available evidence suggested that CHIs combined with XELOX regimen could provide treatment benefits for patients with gastric cancer. Among 13 types of CHIs, Javanica oil emulsion and Compound Kushen injection is the optimal treatment in improving the clinical effectiveness rate and performance status, and Lentinan injection was superior in relieving ADRs.
doi_str_mv 10.1097/MD.0000000000010127
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5895335</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2016538489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-e5d20dec2ad9505988d49627144e956dbf782373ee5ca1bba58cb3f0c699446a3</originalsourceid><addsrcrecordid>eNpdUVtPFDEUbogGVuQXmJg--jLQ68zUB81mQSTZDUQg8tZ0Omd2ijPt2nYl_AF_t2NAVM7Lefgu5_Ih9IaSQ0pUdbQ6PiR_ixLKqh00o5KXhVSleIFmhDBZVKoSe-hVSrcTiVdM7KI9pmRJBaUz9PNr72yPTQSce8ANpIwXvfOQAPcQGzNg52_BZhd8wjaMzYS1-M7lHt-cLM9vcIS1G8HjLkS8NilHZ7E13kL8-B7P8cWXs8vVvJiUm8EZn7GHfBfiNzxCNoXxZrhPLr1GLzszJDh47Pvo-tPJ1eJzsTw_PVvMl4XllOQCZMtIC5aZVkkiVV23QpWsokLAdFLbdFXNeMUBpDW0aYysbcM7YkulhCgN30cfHnw322aE1oLP0Qx6E91o4r0Oxun_Ee96vQ4_tKyV5FxOBu8eDWL4vp2-pUeXLAyD8RC2STNCS8lrUauJyh-oNoaUInRPYyjRvxPUq2P9PMFJ9fbfDZ80fyLjvwA_kJhZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2016538489</pqid></control><display><type>article</type><title>Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>IngentaConnect Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><source>Wolters Kluwer Open Access</source><creator>Zhang, Dan ; Wu, Jiarui ; Wang, Kaihuan ; Duan, Xiaojiao ; Liu, Shi ; Zhang, Bing</creator><creatorcontrib>Zhang, Dan ; Wu, Jiarui ; Wang, Kaihuan ; Duan, Xiaojiao ; Liu, Shi ; Zhang, Bing</creatorcontrib><description>The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer. PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure Database (CNKI), Wan-fang Database, Cqvip Database (VIP), China Biology Medicine disc (CBMdisc) were searched to identify RCTs which focused on CHIs against gastric cancer. The quality assessment of included randomized controlled trials (RCTs) was conducted by the Cochrane risk of bias tool. Standard pair-wise and Bayesian NMAs were performed to compare the efficacy and safety of different CHIs combined with the XELOX regimen via Stata 13.0 and WinBUGS1.4 software. A total of 2316 records were searched, the network of evidence included 26 eligible RCTs involving 13 types of CHIs and 2154 patients. The results suggested that Shenqifuzheng+ XELOX, Huachansu+ XELOX, Kangai+ XELOX, Javanica oil emulsion+ XELOX, Aidi injection+ XELOX might be the optimal treatment for gastric cancer in improving the performance status than using XELOX regimen single, with odds ratios (OR) and 95% confidence intervals (CIs) of 2.74 (1.24, 6.17), 8.27 (1.74, 42.43), 4.28 (1.80, 10.48), 5.14 (1.87, 16.28), 0.20 (0.090, 0.44). At the aspects of ADRs (adverse reactions), Compound Kushen+ XELOX, Lentinan+ XELOX, Xiaoaiping injection+ XELOX could obviously relieve leukopenia than only receiving XELOX regimen, and their ORs and 95% CIs were 5.62 (1.41, 36.24), 8.16 (2.25, 29.43), 5.69 (1.85, 15.77). Furthermore, Disodium cantharidinate and vitamin B6+ XELOX, Shenqifuzheng+ XELOX, Kangai+ XELOX, Lentinan+ XELOX could obviously relieve the nausea and vomiting than receiving the XELOX regimen alone, with ORs and 95% CIs of 5.29 (1.30, 23.96), 2.50 (1.16, 5.26), 2.42 (1.06, 5.63), 9.04 (3.24, 26.73). Nevertheless, CHIs combined with XELOX regimen did not confer higher better clinical effectiveness rate over receiving XELOX regimen alone, with nonstatistically significant between-group differences. As the available evidence suggested that CHIs combined with XELOX regimen could provide treatment benefits for patients with gastric cancer. Among 13 types of CHIs, Javanica oil emulsion and Compound Kushen injection is the optimal treatment in improving the clinical effectiveness rate and performance status, and Lentinan injection was superior in relieving ADRs.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000010127</identifier><identifier>PMID: 29561411</identifier><language>eng</language><publisher>United States: Wolters Kluwer Health</publisher><subject>Antineoplastic Agents - therapeutic use ; Antineoplastic Combined Chemotherapy Protocols ; Deoxycytidine - analogs &amp; derivatives ; Drugs, Chinese Herbal - therapeutic use ; Fluorouracil - analogs &amp; derivatives ; Humans ; Network Meta-Analysis ; Stomach Neoplasms - drug therapy ; Systematic Review and Meta-Analysis</subject><ispartof>Medicine (Baltimore), 2018-03, Vol.97 (12), p.e0127-e0127</ispartof><rights>Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-e5d20dec2ad9505988d49627144e956dbf782373ee5ca1bba58cb3f0c699446a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895335/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895335/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29561411$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Dan</creatorcontrib><creatorcontrib>Wu, Jiarui</creatorcontrib><creatorcontrib>Wang, Kaihuan</creatorcontrib><creatorcontrib>Duan, Xiaojiao</creatorcontrib><creatorcontrib>Liu, Shi</creatorcontrib><creatorcontrib>Zhang, Bing</creatorcontrib><title>Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer. PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure Database (CNKI), Wan-fang Database, Cqvip Database (VIP), China Biology Medicine disc (CBMdisc) were searched to identify RCTs which focused on CHIs against gastric cancer. The quality assessment of included randomized controlled trials (RCTs) was conducted by the Cochrane risk of bias tool. Standard pair-wise and Bayesian NMAs were performed to compare the efficacy and safety of different CHIs combined with the XELOX regimen via Stata 13.0 and WinBUGS1.4 software. A total of 2316 records were searched, the network of evidence included 26 eligible RCTs involving 13 types of CHIs and 2154 patients. The results suggested that Shenqifuzheng+ XELOX, Huachansu+ XELOX, Kangai+ XELOX, Javanica oil emulsion+ XELOX, Aidi injection+ XELOX might be the optimal treatment for gastric cancer in improving the performance status than using XELOX regimen single, with odds ratios (OR) and 95% confidence intervals (CIs) of 2.74 (1.24, 6.17), 8.27 (1.74, 42.43), 4.28 (1.80, 10.48), 5.14 (1.87, 16.28), 0.20 (0.090, 0.44). At the aspects of ADRs (adverse reactions), Compound Kushen+ XELOX, Lentinan+ XELOX, Xiaoaiping injection+ XELOX could obviously relieve leukopenia than only receiving XELOX regimen, and their ORs and 95% CIs were 5.62 (1.41, 36.24), 8.16 (2.25, 29.43), 5.69 (1.85, 15.77). Furthermore, Disodium cantharidinate and vitamin B6+ XELOX, Shenqifuzheng+ XELOX, Kangai+ XELOX, Lentinan+ XELOX could obviously relieve the nausea and vomiting than receiving the XELOX regimen alone, with ORs and 95% CIs of 5.29 (1.30, 23.96), 2.50 (1.16, 5.26), 2.42 (1.06, 5.63), 9.04 (3.24, 26.73). Nevertheless, CHIs combined with XELOX regimen did not confer higher better clinical effectiveness rate over receiving XELOX regimen alone, with nonstatistically significant between-group differences. As the available evidence suggested that CHIs combined with XELOX regimen could provide treatment benefits for patients with gastric cancer. Among 13 types of CHIs, Javanica oil emulsion and Compound Kushen injection is the optimal treatment in improving the clinical effectiveness rate and performance status, and Lentinan injection was superior in relieving ADRs.</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Antineoplastic Combined Chemotherapy Protocols</subject><subject>Deoxycytidine - analogs &amp; derivatives</subject><subject>Drugs, Chinese Herbal - therapeutic use</subject><subject>Fluorouracil - analogs &amp; derivatives</subject><subject>Humans</subject><subject>Network Meta-Analysis</subject><subject>Stomach Neoplasms - drug therapy</subject><subject>Systematic Review and Meta-Analysis</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUVtPFDEUbogGVuQXmJg--jLQ68zUB81mQSTZDUQg8tZ0Omd2ijPt2nYl_AF_t2NAVM7Lefgu5_Ih9IaSQ0pUdbQ6PiR_ixLKqh00o5KXhVSleIFmhDBZVKoSe-hVSrcTiVdM7KI9pmRJBaUz9PNr72yPTQSce8ANpIwXvfOQAPcQGzNg52_BZhd8wjaMzYS1-M7lHt-cLM9vcIS1G8HjLkS8NilHZ7E13kL8-B7P8cWXs8vVvJiUm8EZn7GHfBfiNzxCNoXxZrhPLr1GLzszJDh47Pvo-tPJ1eJzsTw_PVvMl4XllOQCZMtIC5aZVkkiVV23QpWsokLAdFLbdFXNeMUBpDW0aYysbcM7YkulhCgN30cfHnw322aE1oLP0Qx6E91o4r0Oxun_Ee96vQ4_tKyV5FxOBu8eDWL4vp2-pUeXLAyD8RC2STNCS8lrUauJyh-oNoaUInRPYyjRvxPUq2P9PMFJ9fbfDZ80fyLjvwA_kJhZ</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Zhang, Dan</creator><creator>Wu, Jiarui</creator><creator>Wang, Kaihuan</creator><creator>Duan, Xiaojiao</creator><creator>Liu, Shi</creator><creator>Zhang, Bing</creator><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180301</creationdate><title>Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis</title><author>Zhang, Dan ; Wu, Jiarui ; Wang, Kaihuan ; Duan, Xiaojiao ; Liu, Shi ; Zhang, Bing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-e5d20dec2ad9505988d49627144e956dbf782373ee5ca1bba58cb3f0c699446a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Antineoplastic Combined Chemotherapy Protocols</topic><topic>Deoxycytidine - analogs &amp; derivatives</topic><topic>Drugs, Chinese Herbal - therapeutic use</topic><topic>Fluorouracil - analogs &amp; derivatives</topic><topic>Humans</topic><topic>Network Meta-Analysis</topic><topic>Stomach Neoplasms - drug therapy</topic><topic>Systematic Review and Meta-Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Dan</creatorcontrib><creatorcontrib>Wu, Jiarui</creatorcontrib><creatorcontrib>Wang, Kaihuan</creatorcontrib><creatorcontrib>Duan, Xiaojiao</creatorcontrib><creatorcontrib>Liu, Shi</creatorcontrib><creatorcontrib>Zhang, Bing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Dan</au><au>Wu, Jiarui</au><au>Wang, Kaihuan</au><au>Duan, Xiaojiao</au><au>Liu, Shi</au><au>Zhang, Bing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>97</volume><issue>12</issue><spage>e0127</spage><epage>e0127</epage><pages>e0127-e0127</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer. PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure Database (CNKI), Wan-fang Database, Cqvip Database (VIP), China Biology Medicine disc (CBMdisc) were searched to identify RCTs which focused on CHIs against gastric cancer. The quality assessment of included randomized controlled trials (RCTs) was conducted by the Cochrane risk of bias tool. Standard pair-wise and Bayesian NMAs were performed to compare the efficacy and safety of different CHIs combined with the XELOX regimen via Stata 13.0 and WinBUGS1.4 software. A total of 2316 records were searched, the network of evidence included 26 eligible RCTs involving 13 types of CHIs and 2154 patients. The results suggested that Shenqifuzheng+ XELOX, Huachansu+ XELOX, Kangai+ XELOX, Javanica oil emulsion+ XELOX, Aidi injection+ XELOX might be the optimal treatment for gastric cancer in improving the performance status than using XELOX regimen single, with odds ratios (OR) and 95% confidence intervals (CIs) of 2.74 (1.24, 6.17), 8.27 (1.74, 42.43), 4.28 (1.80, 10.48), 5.14 (1.87, 16.28), 0.20 (0.090, 0.44). At the aspects of ADRs (adverse reactions), Compound Kushen+ XELOX, Lentinan+ XELOX, Xiaoaiping injection+ XELOX could obviously relieve leukopenia than only receiving XELOX regimen, and their ORs and 95% CIs were 5.62 (1.41, 36.24), 8.16 (2.25, 29.43), 5.69 (1.85, 15.77). Furthermore, Disodium cantharidinate and vitamin B6+ XELOX, Shenqifuzheng+ XELOX, Kangai+ XELOX, Lentinan+ XELOX could obviously relieve the nausea and vomiting than receiving the XELOX regimen alone, with ORs and 95% CIs of 5.29 (1.30, 23.96), 2.50 (1.16, 5.26), 2.42 (1.06, 5.63), 9.04 (3.24, 26.73). Nevertheless, CHIs combined with XELOX regimen did not confer higher better clinical effectiveness rate over receiving XELOX regimen alone, with nonstatistically significant between-group differences. As the available evidence suggested that CHIs combined with XELOX regimen could provide treatment benefits for patients with gastric cancer. Among 13 types of CHIs, Javanica oil emulsion and Compound Kushen injection is the optimal treatment in improving the clinical effectiveness rate and performance status, and Lentinan injection was superior in relieving ADRs.</abstract><cop>United States</cop><pub>Wolters Kluwer Health</pub><pmid>29561411</pmid><doi>10.1097/MD.0000000000010127</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2018-03, Vol.97 (12), p.e0127-e0127
issn 0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5895335
source MEDLINE; DOAJ Directory of Open Access Journals; IngentaConnect Open Access; PubMed Central; Alma/SFX Local Collection; EZB Electronic Journals Library; Wolters Kluwer Open Access
subjects Antineoplastic Agents - therapeutic use
Antineoplastic Combined Chemotherapy Protocols
Deoxycytidine - analogs & derivatives
Drugs, Chinese Herbal - therapeutic use
Fluorouracil - analogs & derivatives
Humans
Network Meta-Analysis
Stomach Neoplasms - drug therapy
Systematic Review and Meta-Analysis
title Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A08%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Which%20are%20the%20best%20Chinese%20herbal%20injections%20combined%20with%20XELOX%20regimen%20for%20gastric%20cancer?:%20A%20PRISMA-compliant%20network%20meta-analysis&rft.jtitle=Medicine%20(Baltimore)&rft.au=Zhang,%20Dan&rft.date=2018-03-01&rft.volume=97&rft.issue=12&rft.spage=e0127&rft.epage=e0127&rft.pages=e0127-e0127&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000010127&rft_dat=%3Cproquest_pubme%3E2016538489%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2016538489&rft_id=info:pmid/29561411&rfr_iscdi=true